EVGN · Evogene Ltd.
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
Insider Sentiment Score
Peer-relative 0–100 rank of how aggressively insiders accumulated over the trailing 90 days. See the full ranking.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-08-11 | RECANATI LEON |
Director |
Buy↑
|
Ordinary Shares
|
460,000 |
| 2026-08-04 | RECANATI LEON |
Director |
Buy↑
Filing footnotes — Ordinary Shares (Direct)
The price reported in column 4 of this row is a weighted average price. These shares were purchased in multiple transactions on August 4, 2026 within a range of prices per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price. |
Ordinary Shares
|
800,000 |
| 2026-06-04 | Tarcic Gabi |
Chief Development Officer |
Buy↑
|
Ordinary Shares
|
1,129 |